Clinical trials of medicines containing genetically modified organisms

A webinar on clinical trials of medicinal products containing or consisting of genetically modified microorganisms is being organized by the Swedish Agency for Occupational Health and Safety and the Swedish Agency for Medicinal Products.

The purpose of the webinar is to clarify the requirements for clinical trials of medicinal products containing or consisting of genetically modified (micro-) organisms with a focus on:

  • Regulatory framework and boundaries between authorities’ responsibilities
  • Application for deliberate release and notification/application for contained use – and what to submit to the authorities.

The webinar is aimed at people in industry, academia, university hospitals and hospital pharmacies involved in clinical trials of medicines consisting of genetically modified (micro) organisms.

Read more and register here.